. Alarcon-SegoviaDBabbRRFairbairnJFHagedornAB: Erythermalgia. A clue to the early diagnosis of myeloproliferative disorders. Arch Intern Med.117(4):511–5, 1966. http://dx.doi.org/10.1001/archinte.117.4.511.
2.
. ChanMKTuckerATMaddenS: Erythromelalgia: an endothelial disorder responsive to sodium nitroprusside. Arch Dis Child.87(3):229–230, 2002. http://dx.doi.org/10.1136/adc.87.3.229.
. EstacionMDib-HajjSDBenkePJ: NaV1.7 Gainof-Function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci.28(43):11079–11088, 2008. http://dx.doi.org/10.1523/JNEUROSCI.3443-08.2008.
. MuhiddinKAGallenIWHarriesSPearceVR: The use of capsaicin cream in a case of erythromelalgia. Postgrad Med Journal.70:841–843, 1994. http://dx.doi.org/10.1136/pgmj.70.829.841.
7.
. NathanARoseJBGuiteJWHehirDMilovcichK: Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment. Pediatrics.115(4): e504–507, 2005. http://dx.doi.org/10.1542/peds.2004-1395.
8.
. NatkunarajahJAthertonDElmslieFMansourSMortimerP: Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel. Clin Exp Dermatol. Epub ahead of print, 2009. http://dx.doi.org/10.1111/j.1365-2230.2009.03355.x.
. NovellaSPHisamaFMDib-HajjSDWaxmanSG: A case of inherited erythromelalgia. Nat Clin Pract Neurol.3(4):229–234, 2007. http://dx.doi.org/10.1038/ncpneuro0425.
11.
. ReedKBDavisMD: Incidence of erythromelalgia: a population-based study in Olmsted County, Minnesota. J Eur Acad Dermatol and Venereol.23(1):13–15, 2008. http://dx.doi.org/10.1111/j.1468-3083.2008.02938.x.
